BIOTECH: KYTHERA REACHES MILESTONE AS FDA TO REVIEW ANTI-FAT COMPOUND.
Investors See Double Over Chin Drug
Monday, July 28, 2014
After nearly a decade in the laboratory and accumulated losses of $172 million, Kythera Biopharmaceuticals Inc...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 26 biweekly issues
- Subscriber-only digital content for prime stories
- Book of Lists — the most comprehensive business resource in the Valley region